In conclusion, to the best of our knowledge, the current study was the first to simultaneously assess serum IGF-I, IGF-IR, VEGF-A and TGF-β1 levels and their interrelations in two well defined groups of patients with BC (TNBC and non-TNBC). The gene discussed is IGF1; the disease is breast cancer.